Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jonathan I. Silverberg, Evangeline Pierce, Meghan Feely, Amber Reck Atwater, Amy Schrader, Eric A. Jones, Swapna S. Dave & Eric L. Simpson. (2023) Disease burden among patients with atopic dermatitis treated with systemic therapy for 4–12 months: results from the CorEvitas Atopic Dermatitis Registry. Journal of Dermatological Treatment 34:1.
Read now
Read now
Shelley K. Uppal, Donovan G. Kearns, Vipawee S. Chat, George Han & Jashin J. Wu. (2022) Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitis. Journal of Dermatological Treatment 33:2, pages 626-636.
Read now
Read now
Estefânia Vangelie Ramos Campos, Patrícia Luiza De Freitas Proença, Lorena Doretto-Silva, Vinicius Andrade-Oliveira, Leonardo Fernandes Fraceto & Daniele Ribeiro de Araujo. (2020) Trends in nanoformulations for atopic dermatitis treatment. Expert Opinion on Drug Delivery 17:11, pages 1615-1630.
Read now
Read now
Alexander N. Howell, Rima I. Ghamrawi, Lindsay C. Strowd & Steven R. Feldman. (2020) Pharmacological management of atopic dermatitis in the elderly. Expert Opinion on Pharmacotherapy 21:7, pages 761-771.
Read now
Read now
Articles from other publishers (30)
Lawrence F. Eichenfield, Richard G. Gower, JinHua Xu, Maryam S. Alam, John C. Su, Daniela E. Myers, Paul Sanders, Bonnie Vlahos, Chuanbo Zang, Jar Lan & John Werth. (2023) Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study. American Journal of Clinical Dermatology.
Crossref
Crossref
Ivan Cherrez-Ojeda, Karla Robles-Velasco, Simon Francis Thomsen, German D. Ramon, Jorge Sánchez, Jonathan A. Bernstein & Benjamin Hidalgo. (2023) Challenges in the Use of the Treat-to-Target Strategy in Atopic Dermatitis in Latin America: A Case Series Review. Dermatology and Therapy 13:3, pages 661-672.
Crossref
Crossref
Bader Bashrahil, Ziyad Alzahrani, Sahal Samarkandy, Abdullah Aman & Abdulhadi Jfri. (2023) The efficacy and safety of lebrikizumab monotherapy for the management of moderate-to-severe atopic dermatitis: A systematic review and meta-analysis. Frontiers in Medicine 9.
Crossref
Crossref
Gehan A Pendlebury, Peter Oro, Kerstyn Ludlow, Drew Merideth, William Haynes & Vikas Shrivastava. (2023) Relevant Dermatoses Among U.S. Military Service Members: An Operational Review of Management Strategies and Telemedicine Utilization. Cureus.
Crossref
Crossref
Lisa Bloudek, Lawrence F. Eichenfield, Jonathan I. Silverberg, Vijay N. Joish, Jennifer H. Lofland, Kang Sun, Matthias Augustin, Kristen Migliaccio-Walle & Sean D. Sullivan. (2022) Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies. American Journal of Clinical Dermatology 24:1, pages 109-117.
Crossref
Crossref
Matthias Augustin, Antonio Costanzo, Andrew Pink, Julien Seneschal, Christopher Schuster, Can Mert, Mariana Guerreiro, Nicole Tietz, Susanne Grond & Marjolein De Bruin-Weller. (2022) Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey. Acta Dermato-Venereologica 102, pages adv00830.
Crossref
Crossref
José Javier Morales-Núñez, José Francisco Muñoz-Valle, Andrea Carolina Machado-Sulbarán, Saúl Alberto Díaz-Pérez, Paola Carolina Torres-Hernández, Beatriz Verónica Panduro-Espinoza, Jonathan Adrián Gallegos-Díaz de Leon, Carlos David Munguía-Ramirez & Jorge Hernández-Bello. (2022) Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies. Immunology Letters 251-252, pages 20-28.
Crossref
Crossref
Carolina Cabalín, Guillermo Pérez-Mateluna, Carolina Iturriaga, Carlos A. CamargoJr.Jr. & Arturo Borzutzky. (2022) Oral vitamin D modulates the epidermal expression of the vitamin D receptor and cathelicidin in children with atopic dermatitis. Archives of Dermatological Research 315:4, pages 761-770.
Crossref
Crossref
Georgia Pappa, Dimitrios Sgouros, Konstantinos Theodoropoulos, Antonios Kanelleas, Evangelia Bozi, Stamatios Gregoriou, Konstantinos Krasagakis & Alexander Katoulis. (2022) The IL-4/-13 Axis and Its Blocking in the Treatment of Atopic Dermatitis. Journal of Clinical Medicine 11:19, pages 5633.
Crossref
Crossref
L. von Kobyletzki, N. Ballardini, D. Henrohn, M.P. Neary, G. Ortsäter, K. Geale, A. Rieem Dun, I. Lindberg, A. De Geer, P. Neregård, A. Cha, J.C. Cappelleri, W. Romero & J.P. Thyssen. (2022)
Care pathways in atopic dermatitis: a retrospective
population‐based
cohort study
. Journal of the European Academy of Dermatology and Venereology 36:9, pages 1456-1466.
Crossref
Crossref
Sarah W. Matthews, Stephanie Binick, Karen J. Sherman & Andy J. Chien. (2022) A Pragmatic Study on Nurse-Led Home Phototherapy. Journal of the Dermatology Nurses' Association 14:5, pages 203-213.
Crossref
Crossref
Jashin J. Wu, Chih-ho Hong, Joseph F. Merola, David Gruben, Erman Güler, Claire Feeney, Ankur Bhambri, Daniela E. Myers & Marco DiBonaventura. (2022) Predictors of nonresponse to dupilumab in patients with atopic dermatitis. Annals of Allergy, Asthma & Immunology 129:3, pages 354-359.e5.
Crossref
Crossref
Piyu Parth Naik. (2022) Recent insights into the management of treatment-resistant pediatric atopic dermatitis. International Journal of Women’s Dermatology 8:2, pages e023.
Crossref
Crossref
Hayan Jeong, Hyo-Jin Chong, Jangho So, Yejin Jo, Tae-Young Yune & Bong-Gun Ju. (2022) Ghrelin Represses Thymic Stromal Lymphopoietin Gene Expression through Activation of Glucocorticoid Receptor and Protein Kinase C Delta in Inflamed Skin Keratinocytes. International Journal of Molecular Sciences 23:7, pages 3977.
Crossref
Crossref
Jafar Salimian, Zahra Salehi, Ali Ahmadi, Alireza Emamvirdizadeh, Seyyed Masoud Davoudi, Mehrdad Karimi, Mohsen Korani & Sadegh Azimzadeh Jamalkandi. (2022) Atopic dermatitis: molecular, cellular, and clinical aspects. Molecular Biology Reports 49:4, pages 3333-3348.
Crossref
Crossref
N. N. Potekaev, G. P. Tereshchenko, R. A. Khanferyan & A. L. Savastenko. (2022) Immune mechanisms of atopic dermatitis and new approaches to targeted biological therapy. Meditsinskiy sovet = Medical Council:3, pages 130-136.
Crossref
Crossref
Paméla Voillot, Brigitte Riche, Michel Portafax, Pierre Foulquié, Anaïs Gedik, Sébastien Barbarot, Laurent Misery, Stéphane Héas, Adel Mebarki, Nathalie Texier & Stéphane Schück. (2022) Social Media Platforms Listening Study on Atopic Dermatitis: Quantitative and Qualitative Findings. Journal of Medical Internet Research 24:1, pages e31140.
Crossref
Crossref
Giampiero Girolomoni & Valentina Maria Busà. (2022) Flare management in atopic dermatitis: from definition to treatment. Therapeutic Advances in Chronic Disease 13, pages 204062232110667.
Crossref
Crossref
Emilia Vassilopoulou, Isabel Skypala, Gavriela Feketea, Radoslaw Gawlik, Audrey Dunn Galvin, Rosan Meyer, Constantinos Pitsios, Raluca Maria Pop, Dermot Ryan, Maria Said, Sophie Scheire, Berber Vlieg‐Boerstra & Inger Kull. (2021) A multi‐disciplinary approach to the diagnosis and management of allergic diseases: An EAACI Task Force. Pediatric Allergy and Immunology 33:1.
Crossref
Crossref
Sanjoy Das, Sentu Das & Malay K. Das. 2022. Nanocosmeceuticals. Nanocosmeceuticals
31
69
.
Garrett Desman, Farah R. Abdulla, Jonas A. Adalsteinsson, Katayun Adhami, Sofia Chaudhry, Samantha R. Ellis, Patrick Emanuel, Jill Gregory, Maija Kiuru, Jennifer Ko, Christiane Querfeld, Richard Scarborough, Jennifer Platt Toyohara, Jonathan P. Ungar, Claudia I. Vidal & Nikki S. Vyas. 2022. Atlas of Dermatology, Dermatopathology and Venereology. Atlas of Dermatology, Dermatopathology and Venereology
161
216
.
Paige L. McKenzie, Sneha Rangu, James R. Treat & Leslie Castelo‐Soccio. (2021) Experience using dupilumab for pediatric atopic dermatitis at a tertiary care c enter: Inadequate response and adverse events. Pediatric Dermatology 38:5, pages 1178-1184.
Crossref
Crossref
Fang Tang, Xueqing Ma, Jiayu Sun, Minghui Ru, Tiansheng Qian, Wengjing Ji, Sifan Qian & Hua Li. (2021) Cell‑penetrating heme oxygenase‑1 in the therapy of atopic dermatitis in mice. Experimental and Therapeutic Medicine 22:3.
Crossref
Crossref
Norami de Moura Barros, Lissiê Lunardi Sbroglio, Maria de Oliveira Buffara, Jessica Lana Conceição e Silva Baka, Allen de Souza Pessoa & Luna Azulay-Abulafia. (2021) Phototherapy. Anais Brasileiros de Dermatologia 96:4, pages 397-407.
Crossref
Crossref
Thanaporn Ratchataswan, Tina M. Banzon, Jacob P. Thyssen, Stephan Weidinger, Emma Guttman-Yassky & Wanda Phipatanakul. (2021) Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect. The Journal of Allergy and Clinical Immunology: In Practice 9:3, pages 1053-1065.
Crossref
Crossref
Lawrence F. Eichenfield, Marco DiBonaventura, Jason Xenakis, Marie-Helene Lafeuille, Mei Sheng Duh, Iman Fakih, Mark Levenberg, Joseph C. Cappelleri & Vanja Sikirica. (2020) Costs and Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: Analysis of a Retrospective Claims Database. Dermatology and Therapy 10:4, pages 791-806.
Crossref
Crossref
Yu.N. Perlamutrov, K.B. Olkhovskaya & A.O. Lyapon. (2020) The place of modern antihistamines in the treatment of atopic dermatitis. Klinicheskaya dermatologiya i venerologiya 19:2, pages 187.
Crossref
Crossref
Anna B. Fishbein, Jonathan I. Silverberg, Eve J. Wilson & Peck Y. Ong. (2020) Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection. The Journal of Allergy and Clinical Immunology: In Practice 8:1, pages 91-101.
Crossref
Crossref
Garrett Desman, Farah R. Abdulla, Jonas A. Adalsteinsson, Katayun Adhami, Sofia Chaudhry, Samantha R. Ellis, Patrick Emanuel, Jill Gregory, Maija Kiuru, Jennifer Ko, Christiane Querfeld, Richard Scarborough, Jennifer Platt Toyohara, Jonathan P. Ungar, Claudia I. Vidal & Nikki S. Vyas. 2020. Atlas of Dermatology, Dermatopathology and Venereology. Atlas of Dermatology, Dermatopathology and Venereology
1
56
.
Galina I. Smirnova & A. A. Korsunsky. (2019) DISORDERS OF SKIN MICROBIOTA AND FORMATION OF ATOPIC DERMATITIS IN CHILDREN. Russian Pediatric Journal 22:4, pages 243-250.
Crossref
Crossref